Stay updated on Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Sign up to get notified when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.

Latest updates to the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded the Locations section and updated to Revision v3.3.3; removed HHS Vulnerability Disclosure, Migration Data Locations, and Revision v3.3.2.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedFooter metadata updated from Revision v3.2.0 to v3.3.2. This is a minor metadata update and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check51 days agoChange DetectedRemoved the temporary government funding status notice from the page; no study content or functionality was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check65 days agoChange DetectedCore trial information such as design, outcomes, eligibility criteria, and locations remains unchanged; observed differences appear to be formatting or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedCore content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check100 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.